顔用注入剤の世界市場規模：製品別、用途別、地域別、範囲および予測

顔用注入剤の市場規模と予測

顔用注入剤の市場規模は、2021年に57億4,605万米ドルと評価され、2023年から2030年にかけて16.91%のCAGRで成長し、2030年には234億4,823万米ドルに達すると予測されています。顔用注入剤の最も一般的な用途は、老化の初期症状を緩和し、美的魅力を高めることです。コラーゲン、ヒアルロン酸、ポリマー、ボツリヌス毒素は、最も定期的に利用される顔用注入剤の一部です。皮膚のしわの減少、皮膚の滑らかさ、唇の増大、しわの除去、にきび治療、傷跡の治療、および他のアプリケーションのための顔の注射治療の人気は、顔の注射剤の市場採用を推進しています。次の研究では、麻痺した声帯の治療のための顔用注入剤の使用は、顔用注入剤市場の成長を後押しすると予測されている米国FDAによって承認のために検討されています。

顔用注入剤の世界市場定義

皮膚充填剤は顔用注入剤の別名です。顔用注入剤には、コラーゲン、カルシウムハイドロキシアパタイト、ヒアルロン酸ベースの治療が含まれ、しわの除去や減少、唇の強化、傷跡の引き上げ、軟部組織の容積減少など、さまざまなタスクを実行することで顔の皮膚を若返らせる。顔用注入剤で対象部位を充填することで、顔のしわや傷を和らげます。しわ取り注射はしわを作る筋肉をほぐし、皮膚充填剤はしわを最小限に抑え、頬や唇にボリュームを与えます。

真皮フィラーはシワに直接注入され、抗シワ注射はシワを作る筋肉を弛緩させます。フィラーは、糖分子またはヒアルロン酸、コラーゲン（豚、牛、死体から採取されたもの、または研究室で合成されたもの）、患者の脂肪、合成ポリマーで構成されています。ハイドロキシアパタイトカルシウム、ポリアミド、ポリアクリレート、ポリ乳酸などは後者の例です。Artisteアシスト・インジェクション・システム」は、2012年に米国市場に導入され、皮膚フィラーの注入に役立っています。

この注入装置は、医師が唇やもみあげを埋めるために使用する注入物の充填速度を管理することにより、患者の不快感や有害事象を軽減することができます。あざ、赤み、不快感、かゆみはすべて、皮膚フィラー手術の失敗の頻繁な副作用です。感染症やアレルギー反応は、瘢痕や腫瘍の原因としては一般的ではありません。眼静脈や網膜静脈の逆行性（突然の）塞栓による失明のような重篤な副作用は、よりまれなケースですが報告されています。

この業界では、技術的なブレークスルーが活用されています。抗酸化表皮パッチは現在、高度な技術革新のもとに開発されています。パッチの底にマイクロニードルを使用することで皮膚に浸透し、抗酸化物質が皮膚の奥深くまで浸透します。これらのパッチは、自宅で肌を落ち着かせ、明るくするための、より良い、より迅速なアプローチとなる可能性があります。抗酸化物質が浸透しやすいパッチは、その潜在能力をフルに発揮し、私たちが望むシワをなめらかにし、肌を明るくする効果が期待できます。この分野に様々な将来の機会をもたらします。

顔用注入剤の世界市場概要

この分野は、Facial Injectables Marketの規模が拡大し、繁栄していることが発見されています。非外科的市場治療、顔用注射充填剤、しわ緩和注射剤はいずれも3倍増となっています。非侵襲的な美容施術は、予測期間中に市場を成長させると思われます。皮膚の損傷は、汚染や数多くのライフスタイルの選択によって引き起こされ、予測期間中の需要を押し上げます。コラーゲン繊維、ヒアルロン酸フィラー、合成フィラーなどが顔の注入剤に使用されます。このクリームは、紫外線ダメージから肌を保護し、悪影響を最小限に抑えながら、肌を保湿し、強化します。

顔用注入剤の市場は、前述のすべての基準によって牽引されています。さらに、形成外科医とそのネットワークの増加が美容施術の需要を促進し、顔用注入剤の需要を押し上げています。また、歯科医を含む他の開業医がクリニックで顔用注入剤を利用するためのFDA認可もあった。歯科医師は、歯科治療後に顔の変形を必要とする多くの患者に遭遇するため、現在、顔注入可能な手順を実行することができます。この結果、顔用注入剤の市場は発展する可能性が高いです。

さらに、治療法や材料の進歩、患者層の変化が、医師や皮膚科医による多様な顔面領域の治療を支援しています。このような技術革新は、医師や皮膚科医が患者のためにカスタマイズされた治療を作成するのに役立ち、より良い結果を得るために組み合わせ製品を使用することを容易にし、世界の顔面注入物市場を推進しています。これらすべての要因が市場の今後の成長に寄与すると予想されます。HA（ヒアルロン酸）やBoNTA（A型ボツリヌス毒素）フィラーのような増幅された製品は、特に顔面下部のプロセスで結果を改善するために併用されます。

これもまた、世界の顔用注入剤市場の拡大を後押ししています。顔用注入剤の生産能力、主要市場パラメータ、前年比成長率、メーカー市場シェアは、業界の機会に影響を与えるすべての側面です。厳しい規制への懸念やアイテムの制限、発疹や発赤などの皮膚トラブルによって成長が制限されています。審美的な用途よりもむしろ、市場の拡大は将来の予測年においていくつかの市場阻害要因によって妨げられると思われます。フィラーの価格が高すぎるため、拡大が制限され、結果として市場規模も縮小します。ダーマル・フィラーの悪影響も、顔用注入剤ビジネスの規模を制限する大きな問題です。

目次

第1章 顔用注入剤の世界市場イントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 顔用注入剤の世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル

第5章 顔用注入剤の世界市場：製品別

• 概要
• A型ボツリヌス毒素
• カルシウムハイドロキシアパタイト（CaHA）
• コラーゲン
• ヒアルロン酸（HA）
• ポリマーフィラー

第6章 顔用注入剤の世界市場：用途別

• 概要
• 治療
• 美容

第7章 顔用注入剤の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 顔用注入剤の世界市場：競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第9章 企業プロファイル

• Suneva Medical, Inc.
• ALLERGAN
• Bloomage BioTechnology Corporation Limited
• Ipsen
• Merz Pharma
• Anika Therapeutics, Inc.
• Medytox, Inc.
• Galderma S.A.
• Prollenium Medical Technologies Inc.
• Sinclair Pharma

第10章 主な発展

• 製品上市／開発
• 合併と買収
• 事業拡大
• パートナーシップと提携

第11章 付録

• 関連調査

Facial Injectables Market Size And Forecast

Facial Injectables Market size was valued at USD 5,746.05 Million in 2021 and is projected to reach USD 23,448.23 Million by 2030 , growing at a CAGR of 16.91% from 2023 to 2030. The most common uses for facial injectables are to alleviate early indications of aging and to enhance aesthetic appeal. Collagens, hyaluronic acids, polymers, and botulinum toxins are some of the most regularly utilized facial injectables. The popularity of face injectable treatment for skin fold reduction, skin smoothening, lip augmentation, wrinkle elimination, acne treatment, scar treatment, and other applications is driving the market adoption of facial injectables. In the following study, the usage of face Injectables for the treatment of paralyzed vocal cords is being considered by the US FDA for approval, which is projected to boost the Facial Injectables Market's growth.

Global Facial Injectables Market Definition

Dermal fillers are another name for facial injectables. Facial injectables include collagen, calcium hydroxyapatite, and hyaluronic acid-based treatments that rejuvenate the facial skin by performing a variety of tasks such as wrinkle removal and reduction, lip enhancement, scar elevating, and soft tissue volume reduction. Filling the target area with facial injectables soothes wrinkles and scars on the face. Anti-wrinkle injections relax the muscles that produce wrinkles, while dermal fillers minimize wrinkles and add volume to the cheeks and lips.

Dermal fillers are injected directly into the wrinkles, while anti-wrinkle injections relax the muscles that generate wrinkles. Fillers are constructed of sugar molecules or hyaluronic acids, collagens (that can come from swine, cows, and cadavers, or be synthesized in a lab), the patient's fat, and synthetic polymers. Calcium hydroxyapatite, polyamide, polyacrylate, and polylactic acid are examples of the latter. The "Artiste Assisted Injection System" was introduced to the US market in 2012 to help in dermal filler distribution.

The injecting device can reduce patient discomfort and adverse events by managing the rate of filling of the injection which is being used by the physician to fill in the lip and frown lines. Bruising, redness, discomfort, and itching are all frequent side effects of a botched dermal filler operation. Infection or allergic reactions are fewer common causes of scarring and tumors. Serious side effects such as blindness from retrograde (abrupt) embolization of the ophthalmic and retinal veins have been reported on a more uncommon basis.

The industry makes use of technological breakthroughs. Antioxidant epidermal patches are now being developed at a high level of innovation. The use of a microneedle on the bottom of the patches penetrates the skin, allowing antioxidants to go deep into the skin. These patches could be a better, faster approach to calming and lightening your skin at home. Patches with better antioxidant penetration will reach their full potential, allowing them to give the wrinkle-smoothing and skin-brightening benefits we want. Providing a variety of future chances for the sector.

Global Facial Injectables Market Overview

The sector has been discovered to be flourishing, with an increase in the size of the Facial Injectables Market. Non-surgical market treatments, facial injectable fillers, and wrinkle relaxer injectables have all seen a three-fold increase. Non-invasive aesthetic procedures will grow the market during the projection period. Skin damage is caused by pollution and numerous lifestyle choices, which drive up demand during the projection period. Collagen fibers, hyaluronic acid fillers, and synthetic fillers are used to make facial injectables. This cream moisturizes and enhances your skin while also protecting it from UV damage and having minimal negative effects.

The market for face injectables is driven by all of the aforementioned criteria. Furthermore, the growing number of plastic surgeons and their networks is driving demand for aesthetic procedures, which is boosting demand for face injectables. There was also FDA authorization for other practitioners, including dentists, to utilize face Injectables in their clinics. Dentists can now perform face injectable procedures because they encounter many patients requiring facial transformation after dental treatments. The market for facial injectables is likely to develop as a result of this.

In addition, advances in treatments and materials, as well as changes in patient demographics, are assisting physicians and dermatologists in treating diverse facial areas. These innovations help physicians and dermatologists create customized treatments for patients and make it easier to use combination products to achieve better outcomes, propelling the worldwide Facial Injectables Market. All of these factors are expected to contribute to the market's future growth. Amplified products like HA (Hyaluronic Acid) and BoNTA (Botulinum Toxin Type A) fillers are used in conjunction to improve outcomes, especially in the lower facial processes.

This also fuels the worldwide Facial Injectables Market's expansion. The capacity of face injectables, major market parameters, year-over-year growth rate, and manufacturer market share are all aspects that influence the industry's opportunities. The growth is restricted by tight regulatory concerns and limits on the items, as well as skin problems such as rashes and redness. Rather than aesthetic applications, the market's expansion will be hampered by several market-hindering factors in the future projection year. Filler prices are too high, limiting expansion and, as a result, market size. The negative effects of dermal fillers are also a major issue limiting the size of the facial injectable business.

Global Facial Injectables Market Segmentation Analysis

The Global Facial Injectables Market is segmented on the basis of Product, Application, and Geography.

Facial Injectables Market, By Product

• Botulinum Toxin Type A
• Calcium Hydroxylapatite (CaHA)
• Collagen
• Hyaluronic Acid (HA)
• Polymer Fillers

Based on Product, the market is bifurcated into Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Collagen, Hyaluronic Acid (HA), and Polymer Fillers. The hyaluronic acid segment dominated the market, and it is predicted to increase at a healthy rate over the next few years. The increasing use of hyaluronic acid in the cosmetics industry is likely to fuel growth. Because of its high-water retention qualities and low allergic reactions, hyaluronic acid has become a staple in cosmetics. Hyaluronic acid segment growth includes a moisture-binding feature that helps preserve and enhance the vital moisture held to account for the plumpness of the facial skin. The segment's rise is fuelled by growing demands for cosmetic surgeries and an increase in the number of facial surgeries done.

Facial Injectables Market, By Application

• Therapeutics
• Aesthetics

Based on Application, the market is bifurcated into Therapeutics and Aesthetics. Increasing use of facial injectables for aesthetic procedures such as treatment of parentheses lines, wrinkles on the face, lip lines, lip augmentation, lip border restoration, perioral lines, crow's feet lines, frown lines, glabellar lines, filling furrows (deep wrinkles), periorbital wrinkles, superficial lines, acne scars, tear troughs, marionette lines, lipoatrophy of the face, nasopharyngeal. In the future years, demand for facial injectables for cosmetic purposes is predicted to rise due to a growing interest in physical appearance and income growth among middle-class people in developing nations such as India.

Facial Injectables Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Regional Analysis, the Global Facial Injectables Market is classified into North America, Europe, Asia Pacific, and Rest of the world. North America led the market in 2020, accounting for more than 41.0 percent of total sales. The high elderly population in the United States and Canada is expected to drive demand for face injectables over the projected period. Botox injections were discovered to have jumped by 845 percent. As a result, in the coming years, North America is likely to be a major income generator for facial injectables. The Asia Pacific market is expected to increase at a quick rate. Among the countries that help the region are India, Australia, and South Korea. In these developing countries, a growing emphasis on physical attractiveness is projected to drive the desire for facial injectable treatments. India is expected to be the largest economy in the world by 2050.

Key Players

• The "Global Facial Injectables Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Suneva Medical Inc., ALLERGAN, Bloomage BioTechnology Corporation Limited, Ipsen, Merz Pharma, Anika Therapeutics Inc., Medytox Inc, Galderma S.A, Prollenium Medical Technologies Inc, Sinclair Pharma.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• The International Society of Aesthetic Plastic Surgery in the United States came in first for non-surgical product discovery. Botulinum toxin and hyaluronic acid were the most well-known injectables identified so far.
• In June 2020, For persons above the age of 21, to reduce wrinkles The FDA granted Allergan Aesthetics approval to develop a variety of cosmetic products. It also acquired FDA approval for the use of hyaluronic acid gel for cheeks to treat age-related disorders from the Food and Drug Administration.
• In August 2018, Antares Pharma and Pfizer Inc. collaborated to develop the rescue pen, an injectable medication device.
• HUMIRA Pen, face injectable fillers, is utilized for human anti-tumor necrosis factor-alpha monoclonal antibodies in the Facial Injectables Market forecast. Patients with rheumatoid arthritis use this injectable medicine, which increases its market demand.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL FACIAL INJECTABLES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL FACIAL INJECTABLES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model

5 GLOBAL FACIAL INJECTABLES MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Botulinum Toxin Type A
• 5.3 Calcium Hydroxylapatite (CaHA)
• 5.4 Collagen
• 5.5 Hyaluronic Acid (HA)
• 5.6 Polymer Fillers

6 GLOBAL FACIAL INJECTABLES MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Therapeutics
• 6.3 Aesthetics

7 GLOBAL FACIAL INJECTABLES MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL FACIAL INJECTABLES MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Suneva Medical, Inc.
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 ALLERGAN
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Bloomage BioTechnology Corporation Limited
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Ipsen
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Merz Pharma
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Anika Therapeutics, Inc.
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Medytox, Inc.
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Galderma S.A.
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Prollenium Medical Technologies Inc.
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Sinclair Pharma
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research